Literature DB >> 775290

Plasmids controlling synthesis of hemolysin in Escherichia coli. II. Polynucleotide sequence relationship among hemolytic plasmids.

B Royer-Pokora, W Goebel.   

Abstract

Plasmids of three different sizes, designated as plasmid A (mw: 65 X 10(6), plasmid B (mw: 41 X 10(6) and plasmid C (mw: 32 X 10(6) respectively, have been isolated from various hemolytic wild-type strains of E. coli. DNA-DNA hybridization was performed to determine their relationship. The wild-type strain, PM167a, harbours plasmids of all three sizes. Hybridization studies indicate that all three plasmids share extented sequence homologies but that plasmid A is not composed of plasmids B and C. Hybridization between plasmids of the donor strain and those of appropriate transconjugants demonstrates that in some cases plasmids with identical size are not longer completely homologous in their nucleotide sequences. This indicates that despite their defined sizes these plasmids are not stable genetic entities, but rather they undergo frequently recombination and dissociation during conjugation. In one particular transconjugant strain, K12-PM152/1, a plasmid D was found which is a stable recombined molecule of plasmids B and C of the original strain. Plasmids of size B found as the only extrachromosomal elements in a hemolytic wild-type strain (P224) and two transconjugant strains (e.g. K12-CM20 and K12-PM167/1) share extended nucleotide sequence homologies but are not identical. Little sequence homology was observed between two different hemolytic plasmids and the F and the Col Ib plasmids suggesting that the former do not belong to either the F-like or the I-like group of plasmids. Another hemolytic plasmid is F-like based on its sequence homologies with the F factor.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 775290     DOI: 10.1007/bf02428106

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  14 in total

1.  Molecular studies of R factor compatibility groups.

Authors:  N D Grindley; G O Humphreys; E S Anderson
Journal:  J Bacteriol       Date:  1973-07       Impact factor: 3.490

2.  Polynucleotide sequence relationships among some bacterial plasmids.

Authors:  P Guerry; S Falkow
Journal:  J Bacteriol       Date:  1971-07       Impact factor: 3.490

3.  The isolation and properties of non-restricting mutants of two different host specificities associated with drug resistance factors.

Authors:  D Bannister; S W Glover
Journal:  J Gen Microbiol       Date:  1970-04

4.  Strand-specific supercoiled DNA-protein relaxation complexes: comparison of the complexes of bacterial plasmids ColE1 and ColE2.

Authors:  D G Blair; D B Clewell; D J Sheratt; D R Helinski
Journal:  Proc Natl Acad Sci U S A       Date:  1971-01       Impact factor: 11.205

5.  Sex pili and the classification of sex factors in the enterobacteriaceae.

Authors:  A M Lawn; G G Meynell; E Meynell; N Datta
Journal:  Nature       Date:  1967-10-28       Impact factor: 49.962

6.  The transmissible nature of the genetic factor in Escherichia coli that controls haemolysin production.

Authors:  H W Smith; S Halls
Journal:  J Gen Microbiol       Date:  1967-04

7.  A dye-buoyant-density method for the detection and isolation of closed circular duplex DNA: the closed circular DNA in HeLa cells.

Authors:  R Radloff; W Bauer; J Vinograd
Journal:  Proc Natl Acad Sci U S A       Date:  1967-05       Impact factor: 11.205

8.  Origin of the TEM-beta-lactamase gene found on plasmids.

Authors:  F Heffron; R Sublett; R W Hedges; A Jacob; S Falkow
Journal:  J Bacteriol       Date:  1975-04       Impact factor: 3.490

9.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

10.  Isolation and characterization of supercoiled circular deoxyribonucleic acid from beta-hemolytic strains of Escherichia coli.

Authors:  W Goebel; H Schrempf
Journal:  J Bacteriol       Date:  1971-05       Impact factor: 3.490

View more
  9 in total

1.  Drug resistance in group D streptococci of clinical and nonclinical origin: prevalence, transferability, and plasmid properties.

Authors:  J D van Embden; H W Engel; B van Klingeren
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

2.  Transposition and insertion of intact, deleted and enlarged ampicillin transposon Tn3 from mini-R1 (Rsc) plasmids into transfer factors.

Authors:  W Goebel; W Lindenmaier; F Pfeifer; H Schrempf; B Schelle
Journal:  Mol Gen Genet       Date:  1977-11-29

3.  Determination of the functions of hemolytic plasmid pHly152 of Escherichia coli.

Authors:  A Noegel; U Rdest; W Goebel
Journal:  J Bacteriol       Date:  1981-01       Impact factor: 3.490

4.  Several copies of the same insertion sequence are present in alpha-hemolytic plasmids belonging to four different incompatibility groups.

Authors:  J C Zabala; F de la Cruz; J M Ortiz
Journal:  J Bacteriol       Date:  1982-07       Impact factor: 3.490

Review 5.  Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity.

Authors:  S J Cavalieri; G A Bohach; I S Snyder
Journal:  Microbiol Rev       Date:  1984-12

6.  Hemolysin plasmid coding for the virulence of a nephropathogenic Escherichia coli strain.

Authors:  C Waalwijk; J F van den Bosch; D M MacLaren; J de Graaff
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

7.  Genetics of hemolysin of Escherichia coli.

Authors:  S I Hull; R A Hull; B H Minshew; S Falkow
Journal:  J Bacteriol       Date:  1982-08       Impact factor: 3.490

8.  Hemolysis determinant common to Escherichia coli hemolytic plasmids of different incompatibility groups.

Authors:  F de la Cruz; D Müller; J M Ortiz; W Goebel
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

9.  Plasmid cistrons controlling synthesis and excretion of the exotoxin alpha-haemolysin of Escherichia coli.

Authors:  A Noegel; U Rdest; W Springer; W Goebel
Journal:  Mol Gen Genet       Date:  1979-10-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.